NCT01454310

Brief Summary

The purpose of the study is to compare an acellular epithelial skin substitute with autologous split-thickness skin grafts (STSGs) in deep partial-thickness burns. The objective is to evaluate skin quality and scar formation by using subjective and objective burn scar assessments in order to present valuable data for another additional option of wound coverage in deep partial-thickness burns. The investigators hypothesized that the acellular epithelial skin substitute is at least not inferior to autologous skin grafts.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
18

participants targeted

Target at below P25 for phase_4

Timeline
Completed

Started Nov 2010

Shorter than P25 for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2010

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2011

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2011

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

October 15, 2011

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 19, 2011

Completed
Last Updated

October 19, 2011

Status Verified

October 1, 2011

Enrollment Period

8 months

First QC Date

October 15, 2011

Last Update Submit

October 18, 2011

Conditions

Keywords

Skin substitutesSplit-thickness skin graftBurn woundScar formationSkin quality

Outcome Measures

Primary Outcomes (1)

  • Time (in days +/- standarddeviation) to complete re-epithelialisation in acellular skin substitue area versus autologous skin

    Time to complete re-epithelialisation measured in days after surgery

    1 year

Secondary Outcomes (1)

  • Skin quality- ratio acellular skin substitute/healthy skin versus ratio autologous skin/healthy skin

    1 year

Study Arms (2)

Acellular skin substitute

EXPERIMENTAL
Device: Wound coverage by acellular skin substitute

Autologous skin graft

ACTIVE COMPARATOR
Device: Autologous skin

Interventions

Burn wounds are covered by an acellular skin substitute and remains 10-14 days that peals away in line with re-epithelialisation

Also known as: Suprathel
Acellular skin substitute

Matched burn wound is covered by autologous skin after tangential excision.

Autologous skin graft

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients older than 18 years of age
  • verified deep partial-thickness burns
  • early tangential excision of burn wound (3-5 days after trauma)

You may not qualify if:

  • Pregnancy
  • ABSI-Score \>13
  • Active tumor or immune-mediated disease
  • Patient refusal

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medical University of Vienna, Burn Center, Department of Plastic and Reconstructive Surgery

Vienna, Vienna, 1090, Austria

Location

Related Publications (1)

  • Uhlig C, Rapp M, Hartmann B, Hierlemann H, Planck H, Dittel KK. Suprathel-an innovative, resorbable skin substitute for the treatment of burn victims. Burns. 2007 Mar;33(2):221-9. doi: 10.1016/j.burns.2006.04.024. Epub 2006 Nov 2.

    PMID: 17084030BACKGROUND

MeSH Terms

Conditions

Burns

Condition Hierarchy (Ancestors)

Wounds and Injuries

Study Officials

  • Lars P Kamolz, MD, PhD, MSc

    Medical University of Vienna

    STUDY CHAIR
  • Maike Keck, MD

    Medical University of Vienna, Department of Plastic and Reconstructive Surgery

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, research assistant

Study Record Dates

First Submitted

October 15, 2011

First Posted

October 19, 2011

Study Start

November 1, 2010

Primary Completion

July 1, 2011

Study Completion

September 1, 2011

Last Updated

October 19, 2011

Record last verified: 2011-10

Locations